Logo image of BRZE

BRAZE INC-A (BRZE) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BRZE - US10576N1028 - Common Stock

36.19 USD
+5.54 (+18.08%)
Last: 12/10/2025, 8:00:01 PM
36.04 USD
-0.15 (-0.41%)
Pre-Market: 12/11/2025, 8:00:01 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BRZE. BRZE was compared to 280 industry peers in the Software industry. BRZE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BRZE shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

BRZE had positive earnings in the past year.
In the past year BRZE had a positive cash flow from operations.
BRZE had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BRZE reported negative operating cash flow in multiple years.
BRZE Yearly Net Income VS EBIT VS OCF VS FCFBRZE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -50M -100M

1.2 Ratios

BRZE's Return On Assets of -10.64% is on the low side compared to the rest of the industry. BRZE is outperformed by 63.93% of its industry peers.
With a Return On Equity value of -18.17%, BRZE perfoms like the industry average, outperforming 42.14% of the companies in the same industry.
Industry RankSector Rank
ROA -10.64%
ROE -18.17%
ROIC N/A
ROA(3y)-15.85%
ROA(5y)-15.52%
ROE(3y)-27.38%
ROE(5y)-29.17%
ROIC(3y)N/A
ROIC(5y)N/A
BRZE Yearly ROA, ROE, ROICBRZE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 -10 -20 -30 -40

1.3 Margins

BRZE has a Gross Margin (68.79%) which is in line with its industry peers.
In the last couple of years the Gross Margin of BRZE has grown nicely.
BRZE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.04%
GM growth 5Y1.88%
BRZE Yearly Profit, Operating, Gross MarginsBRZE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

6

2. Health

2.1 Basic Checks

BRZE does not have a ROIC to compare to the WACC, probably because it is not profitable.
BRZE has more shares outstanding than it did 1 year ago.
BRZE has more shares outstanding than it did 5 years ago.
There is no outstanding debt for BRZE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BRZE Yearly Shares OutstandingBRZE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
BRZE Yearly Total Debt VS Total AssetsBRZE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 5.22 indicates that BRZE is not in any danger for bankruptcy at the moment.
BRZE has a Altman-Z score of 5.22. This is in the better half of the industry: BRZE outperforms 70.71% of its industry peers.
BRZE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.22
ROIC/WACCN/A
WACC10.97%
BRZE Yearly LT Debt VS Equity VS FCFBRZE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

BRZE has a Current Ratio of 1.37. This is a normal value and indicates that BRZE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.37, BRZE is in line with its industry, outperforming 42.86% of the companies in the same industry.
A Quick Ratio of 1.37 indicates that BRZE should not have too much problems paying its short term obligations.
BRZE has a Quick ratio of 1.37. This is comparable to the rest of the industry: BRZE outperforms 43.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.37
BRZE Yearly Current Assets VS Current LiabilitesBRZE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M

7

3. Growth

3.1 Past

BRZE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1900.00%, which is quite impressive.
Looking at the last year, BRZE shows a very strong growth in Revenue. The Revenue has grown by 25.78%.
BRZE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 43.83% yearly.
EPS 1Y (TTM)1900%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)25.78%
Revenue growth 3Y35.6%
Revenue growth 5Y43.83%
Sales Q2Q%25.51%

3.2 Future

Based on estimates for the next years, BRZE will show a very strong growth in Earnings Per Share. The EPS will grow by 56.56% on average per year.
Based on estimates for the next years, BRZE will show a quite strong growth in Revenue. The Revenue will grow by 17.76% on average per year.
EPS Next Y133.15%
EPS Next 2Y70.55%
EPS Next 3Y69.64%
EPS Next 5Y56.56%
Revenue Next Year21.91%
Revenue Next 2Y19.59%
Revenue Next 3Y18.25%
Revenue Next 5Y17.76%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BRZE Yearly Revenue VS EstimatesBRZE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
BRZE Yearly EPS VS EstimatesBRZE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 90.47 indicates a quite expensive valuation of BRZE.
BRZE's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 26.59. BRZE is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 69.12 indicates a quite expensive valuation of BRZE.
BRZE's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.80, BRZE is valued quite expensively.
Industry RankSector Rank
PE 90.48
Fwd PE 69.12
BRZE Price Earnings VS Forward Price EarningsBRZE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of BRZE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 147.17
EV/EBITDA N/A
BRZE Per share dataBRZE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

BRZE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BRZE's earnings are expected to grow with 69.64% in the coming years.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y70.55%
EPS Next 3Y69.64%

0

5. Dividend

5.1 Amount

No dividends for BRZE!.
Industry RankSector Rank
Dividend Yield N/A

BRAZE INC-A

NASDAQ:BRZE (12/10/2025, 8:00:01 PM)

Premarket: 36.04 -0.15 (-0.41%)

36.19

+5.54 (+18.08%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-09 2025-12-09/amc
Earnings (Next)03-25 2026-03-25/amc
Inst Owners77.58%
Inst Owner Change6.91%
Ins Owners9.5%
Ins Owner Change5.86%
Market Cap4.03B
Revenue(TTM)593.41M
Net Income(TTM)-108.79M
Analysts84.62
Price Target45.73 (26.36%)
Short Float %6.72%
Short Ratio3.5
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)220.59%
Min EPS beat(2)50.17%
Max EPS beat(2)391.01%
EPS beat(4)4
Avg EPS beat(4)272.62%
Min EPS beat(4)50.17%
Max EPS beat(4)523.5%
EPS beat(8)8
Avg EPS beat(8)199.67%
EPS beat(12)12
Avg EPS beat(12)146.67%
EPS beat(16)16
Avg EPS beat(16)117.22%
Revenue beat(2)2
Avg Revenue beat(2)1.97%
Min Revenue beat(2)0.14%
Max Revenue beat(2)3.8%
Revenue beat(4)4
Avg Revenue beat(4)1.38%
Min Revenue beat(4)0.14%
Max Revenue beat(4)3.8%
Revenue beat(8)8
Avg Revenue beat(8)1.72%
Revenue beat(12)12
Avg Revenue beat(12)1.7%
Revenue beat(16)16
Avg Revenue beat(16)2.89%
PT rev (1m)0%
PT rev (3m)2.03%
EPS NQ rev (1m)0.47%
EPS NQ rev (3m)195.94%
EPS NY rev (1m)0%
EPS NY rev (3m)139.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.01%
Valuation
Industry RankSector Rank
PE 90.48
Fwd PE 69.12
P/S 6.15
P/FCF 147.17
P/OCF 109.52
P/B 6.72
P/tB 15.28
EV/EBITDA N/A
EPS(TTM)0.4
EY1.11%
EPS(NY)0.52
Fwd EY1.45%
FCF(TTM)0.25
FCFY0.68%
OCF(TTM)0.33
OCFY0.91%
SpS5.88
BVpS5.38
TBVpS2.37
PEG (NY)0.68
PEG (5Y)N/A
Graham Number6.96
Profitability
Industry RankSector Rank
ROA -10.64%
ROE -18.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.79%
FCFM 4.18%
ROA(3y)-15.85%
ROA(5y)-15.52%
ROE(3y)-27.38%
ROE(5y)-29.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.04%
GM growth 5Y1.88%
F-Score5
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 73.75%
Cap/Sales 1.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 1.37
Altman-Z 5.22
F-Score5
WACC10.97%
ROIC/WACCN/A
Cap/Depr(3y)240.58%
Cap/Depr(5y)230.69%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1900%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y133.15%
EPS Next 2Y70.55%
EPS Next 3Y69.64%
EPS Next 5Y56.56%
Revenue 1Y (TTM)25.78%
Revenue growth 3Y35.6%
Revenue growth 5Y43.83%
Sales Q2Q%25.51%
Revenue Next Year21.91%
Revenue Next 2Y19.59%
Revenue Next 3Y18.25%
Revenue Next 5Y17.76%
EBIT growth 1Y10.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year771.27%
EBIT Next 3Y181.62%
EBIT Next 5Y120.97%
FCF growth 1Y201.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y294.75%
OCF growth 3YN/A
OCF growth 5YN/A

BRAZE INC-A / BRZE FAQ

Can you provide the ChartMill fundamental rating for BRAZE INC-A?

ChartMill assigns a fundamental rating of 4 / 10 to BRZE.


What is the valuation status of BRAZE INC-A (BRZE) stock?

ChartMill assigns a valuation rating of 3 / 10 to BRAZE INC-A (BRZE). This can be considered as Overvalued.


How profitable is BRAZE INC-A (BRZE) stock?

BRAZE INC-A (BRZE) has a profitability rating of 2 / 10.


Can you provide the PE and PB ratios for BRZE stock?

The Price/Earnings (PE) ratio for BRAZE INC-A (BRZE) is 90.48 and the Price/Book (PB) ratio is 6.72.


What is the earnings growth outlook for BRAZE INC-A?

The Earnings per Share (EPS) of BRAZE INC-A (BRZE) is expected to grow by 133.15% in the next year.